How to Buy Revolution Medicines Stock
Revolution Medicines Inc
Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers.
Revolution Medicines stock last closed at $160.06, up 4.02% from the previous day, and has increased 302.46% in one year. It has overperformed other stocks in the Biotechnology industry by 3.74 percentage points. Revolution Medicines stock is currently +370.76% from its 52-week low of $34.00, and -3.87% from its 52-week high of $166.50.
There are currently 212.6M RVMD shares outstanding. The market cap of RVMD is $34.03B. In the past 24 hours, 2.11M RVMD shares were traded.
How to Buy Revolution Medicines Stock
Wondering how to invest in Revolution Medicines stock? Here's how.
- Figure out where to buy Revolution Medicines stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you figure out where to buy Revolution Medicines stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your details.
- Evaluate Revolution Medicines stock: The Revolution Medicines ticker symbol is RVMD. Is Revolution Medicines stock a good investment? Should you buy shares of RVMD? How do RVMD's underlying business fundamentals look? Do top analysts think Revolution Medicines is a good buy? Why has RVMD's stock price moved recently? (Hint: Our stock market analysis website can help you decide if RVMD is a good stock to buy).
- Place your RVMD trade: Decide if you will purchase RVMD shares at the current market price or use a limit order to purchase RVMD shares at a particular price.
- Track your investment in RVMD: Create a watchlist to watch your investment in Revolution Medicines stock.
Step 1: Figure out where to buy Revolution Medicines stock
You need an online brokerage account to access the NASDAQ market and buy RVMD stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Technology to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you can buy RVMD today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new trading account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the best stock market app for beginners, your next step is to transfer the money for your investment:
Check out the video below to see the process of transferring funds into your new brokerage account.
Step 4: Evaluate Revolution Medicines stock
After you have decided on the best place to buy Revolution Medicines stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Revolution Medicines quick stats
Revolution Medicines Due Diligence Score
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on RVMD's stock page.
Is RVMD stock undervalued?
You can use many financial metrics, analyses, models, and charts to gauge RVMD's intrinsic value.
Using relative valuations ratios:
- RVMD could be overvalued based on its P/B ratio of 22.69x, relative to Biotechnology industry P/B ratio of 4.89x
You can do additional valuation analysis on RVMD's stock here.
A quick look at RVMD Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the RVMD balance sheet.
- RVMD has cash burn of 1071733000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the RVMD balance sheet.
Failed Financial Due Diligence Checks:
- RVMD has a relatively high debt to equity ratio of 0.5.
- Total RVMD debt is higher than 5 years ago, relative to shareholder equity.
- RVMD has $1.91B in cash and short term investments. This is not sufficient to cover its annual cash burn of $1.07B.
Is Revolution Medicines stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 16 Equities analysts who research RVMD, the consensus analyst rating on Revolution Medicines is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent RVMD Analyst Ratings
Gregory Renza, a top 3% analyst from Truist Securities assumes RVMD with a strong buy rating and raises their RVMD price target from $116.00 to $179.00, on May 18, 2026.
Truist Securities's Gregory Renza assumed coverage on Revolution Medicines (NASDAQ: RVMD) with a Strong Buy rating. The analyst also raised their price target by 54.3% from $116 to $179.
Revolution Medicines reported its Q1 2026 earnings.
Assuming Truist Securities' coverage, Renza said they consider daraxon to be the "leading anchor" among RAS-mutant cancers.
The analyst predicted that the medication would address 70%+ of the pancreatic ductal adenocarcinoma market.
Further, Renza said they view Revolution Medicines' "first-in-class positioning, high efficacy barrier, and broad trial footprint, as supporting a durable moat and competitive offense."
Earnings Report
For Q1 2026, Revolution Medicines reported:
- EPS of $(2.29), which missed the Zacks Consensus Estimate of $(1.83) and Q1 2025's $(1.13).
- Revenue of $0.00.
Chairman & CEO Mark A. Goldsmith, M.D., Ph.D., commented: “Last month we reported positive results from the RASolute 302 trial of daraxonrasib, demonstrating an unprecedented improvement in overall survival in patients with previously treated metastatic pancreatic cancer.
“These results, which we intend to submit to global health authorities, mark a major advance for patients and strengthen our conviction in our RAS(ON) inhibition strategy across RAS-driven cancers.
"Reinforced by a growing body of evidence supporting our portfolio led by four innovative clinical-stage RAS(ON) inhibitors and continued expansion of our commercialization capabilities, our goal is to build Revolution Medicines into a leading targeted oncology company capable of delivering impactful therapies to patients worldwide.”
Michael Schmidt, a top 2% analyst from Guggenheim maintains RVMD with a strong buy rating and raises their RVMD price target from $175.00 to $205.00, on May 7, 2026.
Robert Driscoll, a top 12% analyst from Wedbush maintains RVMD with a buy rating and raises their RVMD price target from $147.00 to $165.00, on May 7, 2026.
Kelsey Goodwin, a top 7% analyst from Piper Sandler maintains RVMD with a strong buy rating and raises their RVMD price target from $120.00 to $172.00, on May 7, 2026.
Ami Fadia, a top 1% analyst from Needham maintains RVMD with a buy rating and lowers their RVMD price target from $186.00 to $183.00, on May 7, 2026.
You can dig deeper into what analysts are forecasting on the Revolution Medicines stock forecast page.
RVMD Technicals
Is RVMD Growing Revenue?
Last year, RVMD revenue was $0.00. Over the last five year, RVMD's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 32.3%.
Dive into RVMD's earnings and revenue performance here.
Who is buying/selling RVMD?
Over the last year, executives and large shareholders at RVMD have sold more shares than they have bought.
Margaret A. Horn, Chief Operating Officer of RVMD, was the latest RVMD insider to buy. They bought $46,440.30 worth of RVMD shares on Jun 11, 2026.
Get more info about who owns RVMD shares here.
Can I get consistent income from RVMD stock?
No, Revolution Medicines doesn't provide an income stream by paying out dividends.
RVMD Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your RVMD trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open button and your broker will place the order.
If you want additional help buying stocks on eToro, click the helpful video below:
Step 6: Track your investment in RVMD
Now that you own some RVMD shares, you'll want to keep up with your company.
Add RVMD to a watchlist to keep track of your RVMD stock.
RVMD Feed
How to Buy Stock in Revolution Medicines
To summarize, here are the 6 steps to buy stock in Revolution Medicines:
- Figure out where to buy Revolution Medicines stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Evaluate Revolution Medicines stock
- Place your RVMD trade
- Track your investment in RVMD
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Revolution Medicines, add RVMD to your watchlist below.
More Stock Buying Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.